دورية أكاديمية
أعرض في EDS

The Role of Radiomics in Rectal Cancer.

التفاصيل البيبلوغرافية
العنوان: The Role of Radiomics in Rectal Cancer.
المؤلفون: Miranda J; Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 29, New York, NY, 10065, USA., Horvat N; Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 29, New York, NY, 10065, USA. horvatn@mskcc.org., Araujo-Filho JAB; Department of Radiology, Hospital Sirio-Libanes, 91 Adma Jafet, Sao Paulo, SP, 01308-050, Brazil., Albuquerque KS; Department of Radiology, Hospital Beneficência Portuguesa, 637 Maestro Cardim, Sao Paulo, SP, 01323-001, Brazil., Charbel C; Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 29, New York, NY, 10065, USA., Trindade BMC; Department of Radiology, University of Sao Paulo, 75 Dr. Ovídio Pires de Campos, Sao Paulo, SP, 05403-010, Brazil., Cardoso DL; Department of Radiology, Hospital Sirio-Libanes, 91 Adma Jafet, Sao Paulo, SP, 01308-050, Brazil., de Padua Gomes de Farias L; Department of Radiology, University of Sao Paulo, 75 Dr. Ovídio Pires de Campos, Sao Paulo, SP, 05403-010, Brazil., Chakraborty J; Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA., Nomura CH; Department of Radiology, University of Sao Paulo, 75 Dr. Ovídio Pires de Campos, Sao Paulo, SP, 05403-010, Brazil.
المصدر: Journal of gastrointestinal cancer [J Gastrointest Cancer] 2023 Dec; Vol. 54 (4), pp. 1158-1180. Date of Electronic Publication: 2023 May 08.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Springer Science+Business Media Country of Publication: United States NLM ID: 101479627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-6636 (Electronic) NLM ISO Abbreviation: J Gastrointest Cancer Subsets: MEDLINE
أسماء مطبوعة: Publication: 2010- : New York : Springer Science+Business Media
Original Publication: New York, NY : Humana Press
مواضيع طبية MeSH: Positron Emission Tomography Computed Tomography* , Rectal Neoplasms*/diagnostic imaging , Rectal Neoplasms*/therapy, Humans ; Radiomics ; Prognosis ; Magnetic Resonance Imaging/methods
مستخلص: Purpose: Radiomics is a promising method for advancing imaging assessment in rectal cancer. This review aims to describe the emerging role of radiomics in the imaging assessment of rectal cancer, including various applications of radiomics based on CT, MRI, or PET/CT.
Methods: We conducted a literature review to highlight the progress of radiomic research to date and the challenges that need to be addressed before radiomics can be implemented clinically.
Results: The results suggest that radiomics has the potential to provide valuable information for clinical decision-making in rectal cancer. However, there are still challenges in terms of standardization of imaging protocols, feature extraction, and validation of radiomic models. Despite these challenges, radiomics holds great promise for personalized medicine in rectal cancer, with the potential to improve diagnosis, prognosis, and treatment planning. Further research is needed to validate the clinical utility of radiomics and to establish its role in routine clinical practice.
Conclusion: Overall, radiomics has emerged as a powerful tool for improving the imaging assessment of rectal cancer, and its potential benefits should not be underestimated.
(© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
References: GLOBOCAN. World Health Organization - International Agency for Research on Cancer. 2022.
American Cancer Society. Key Statistics for Colorectal Cancer. 2022.
Rizzo S, Botta F, Raimondi S, Origgi D, Fanciullo C, Morganti AG, et al. Radiomics: the facts and the challenges of image analysis. Eur Radiol Exp. 2018;2(1):36. (PMID: 30426318623419810.1186/s41747-018-0068-z)
Gillies RJ, Kinahan PE, Hricak H. Radiomics: Images Are More than Pictures. They Are Data Radiology. 2016;278(2):563–77. (PMID: 26579733)
Shahzadi I, Zwanenburg A, Lattermann A, Linge A, Baldus C, Peeken JC, et al. Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models. Sci Rep. 2022;12(1):10192. (PMID: 35715462920593510.1038/s41598-022-13967-8)
Wagner MW, Namdar K, Biswas A, Monah S, Khalvati F, Ertl-Wagner BB. Radiomics, machine learning, and artificial intelligence-what the neuroradiologist needs to know. Neuroradiology. 2021;63(12):1957–67. (PMID: 34537858844969810.1007/s00234-021-02813-9)
Röhrich S, Hofmanninger J, Prayer F, Müller H, Prosch H, Langs G. Prospects and Challenges of Radiomics by Using Nononcologic Routine Chest CT. Radiol Cardiothorac Imaging. 2020;2(4):e190190. (PMID: 33778599797801810.1148/ryct.2020190190)
Lambin P, Leijenaar RTH, Deist TM, Peerlings J, de Jong EEC, van Timmeren J, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14(12):749–62. (PMID: 2897592910.1038/nrclinonc.2017.141)
Lubner MG, Smith AD, Sandrasegaran K, Sahani DV, Pickhardt PJ. CT Texture Analysis: Definitions, Applications, Biologic Correlates, and Challenges. Radiographics. 2017;37(5):1483–503. (PMID: 2889818910.1148/rg.2017170056)
Shur JD, Doran SJ, Kumar S, Ap Dafydd D, Downey K, O’Connor JPB, et al. Radiomics in Oncology: A Practical Guide. Radiographics. 2021;41(6):1717–32. (PMID: 3459723510.1148/rg.2021210037)
Bera K, Braman N, Gupta A, Velcheti V, Madabhushi A. Predicting cancer outcomes with radiomics and artificial intelligence in radiology. Nat Rev Clin Oncol. 2022;19(2):132–46. (PMID: 3466389810.1038/s41571-021-00560-7)
Maas M, Lambregts DM, Nelemans PJ, Heijnen LA, Martens MH, Leijtens JW, et al. Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving Treatment. Ann Surg Oncol. 2015;22(12):3873–80. (PMID: 26198074459552510.1245/s10434-015-4687-9)
Duldulao MP, Lee W, Streja L, Chu P, Li W, Chen Z, et al. Distribution of residual cancer cells in the bowel wall after neoadjuvant chemoradiation in patients with rectal cancer. Dis Colon Rectum. 2013;56(2):142–9. (PMID: 23303141467406910.1097/DCR.0b013e31827541e2)
Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro Jr U, e Sousa Jr AH, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg. 2004;240(4):711–7; discussion 7–8.
Miranda J, Tan GXV, Fernandes MC, Yildirim O, Sims JA, Araujo-Filho JAB, et al. Rectal MRI radiomics for predicting pathological complete response: Where we are. Clin Imaging. 2022;82:141–9. (PMID: 3482677210.1016/j.clinimag.2021.10.005)
Bibault JE, Giraud P, Housset M, Durdux C, Taieb J, Berger A, et al. Deep Learning and Radiomics predict complete response after neo-adjuvant chemoradiation for locally advanced rectal cancer. Sci Rep. 2018;8(1):12611. (PMID: 30135549610567610.1038/s41598-018-30657-6)
Yuan Z, Frazer M, Zhang GG, Latifi K, Moros EG, Feygelman V, et al. CT-based radiomic features to predict pathological response in rectal cancer: A retrospective cohort study. J Med Imaging Radiat Oncol. 2020;64(3):444–9. (PMID: 3238610910.1111/1754-9485.13044)
Shayesteh SP, Alikhassi A, Fard Esfahani A, Miraie M, Geramifar P, Bitarafan-Rajabi A, et al. Neo-adjuvant chemoradiotherapy response prediction using MRI based ensemble learning method in rectal cancer patients. Phys Med. 2019;62:111–9. (PMID: 3115339010.1016/j.ejmp.2019.03.013)
Bulens P, Couwenberg A, Intven M, Debucquoy A, Vandecaveye V, Van Cutsem E, et al. Predicting the tumor response to chemoradiotherapy for rectal cancer: Model development and external validation using MRI radiomics. Radiother Oncol. 2020;142:246–52. (PMID: 3143136810.1016/j.radonc.2019.07.033)
Petkovska I, Tixier F, Ortiz EJ, Golia Pernicka JS, Paroder V, Bates DD, et al. Clinical utility of radiomics at baseline rectal MRI to predict complete response of rectal cancer after chemoradiation therapy. Abdom Radiol (NY). 2020.
Cusumano D, Dinapoli N, Boldrini L, Chiloiro G, Gatta R, Masciocchi C, et al. Fractal-based radiomic approach to predict complete pathological response after chemo-radiotherapy in rectal cancer. Radiol Med. 2017.
Cui Y, Yang X, Shi Z, Yang Z, Du X, Zhao Z, et al. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Eur Radiol. 2018.
van Griethuysen JJM, Lambregts DMJ, Trebeschi S, Lahaye MJ, Bakers FCH, Vliegen RFA, et al. Radiomics performs comparable to morphologic assessment by expert radiologists for prediction of response to neoadjuvant chemoradiotherapy on baseline staging MRI in rectal cancer. Abdom Radiol (NY). 2020;45(3):632–43. (PMID: 3173470910.1007/s00261-019-02321-8)
Dinapoli N, Barbaro B, Gatta R, Chiloiro G, Casà C, Masciocchi C, et al. Magnetic Resonance, Vendor-independent, Intensity Histogram Analysis Predicting Pathologic Complete Response After Radiochemotherapy of Rectal Cancer. Int J Radiat Oncol Biol Phys. 2018;102(4):765–74. (PMID: 2989120010.1016/j.ijrobp.2018.04.065)
Li Y, Liu W, Pei Q, Zhao L, Güngör C, Zhu H, et al. Predicting pathological complete response by comparing MRI-based radiomics pre- and postneoadjuvant radiotherapy for locally advanced rectal cancer. Cancer Med. 2019;8(17):7244–52. (PMID: 31642204688589510.1002/cam4.2636)
Liu Z, Zhang XY, Shi YJ, Wang L, Zhu HT, Tang Z, et al. Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. Clin Cancer Res. 2017;23(23):7253–62. (PMID: 2893974410.1158/1078-0432.CCR-17-1038)
Li Z, Ma X, Shen F, Lu H, Xia Y, Lu J. Evaluating treatment response to neoadjuvant chemoradiotherapy in rectal cancer using various MRI-based radiomics models. BMC Med Imaging. 2021;21(1):30. (PMID: 33593304788540910.1186/s12880-021-00560-0)
Horvat N, Veeraraghavan H, Khan M, Blazic I, Zheng J, Capanu M, et al. MR Imaging of Rectal Cancer: Radiomics Analysis to Assess Treatment Response after Neoadjuvant Therapy. Radiology. 2018:172300.
Nie K, Shi L, Chen Q, Hu X, Jabbour SK, Yue N, et al. Rectal Cancer: Assessment of Neoadjuvant Chemoradiation Outcome based on Radiomics of Multiparametric MRI. Clin Cancer Res. 2016;22(21):5256–64. (PMID: 2718536810.1158/1078-0432.CCR-15-2997)
Jeon SH, Song C, Chie EK, Kim B, Kim YH, Chang W, et al. Combining Radiomics and Blood Test Biomarkers to Predict the Response of Locally Advanced Rectal Cancer to Chemoradiation. In Vivo. 2020;34(5):2955–65. (PMID: 32871838765252710.21873/invivo.12126)
Li ZY, Wang XD, Li M, Liu XJ, Ye Z, Song B, et al. Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer. World J Gastroenterol. 2020;26(19):2388–402. (PMID: 32476800724364210.3748/wjg.v26.i19.2388)
Yi X, Pei Q, Zhang Y, Zhu H, Wang Z, Chen C, et al. MRI-Based Radiomics Predicts Tumor Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. Front Oncol. 2019;9:552. (PMID: 31293979660673210.3389/fonc.2019.00552)
Chen H, Shi L, Nguyen KNB, Monjazeb AM, Matsukuma KE, Loehfelm TW, et al. MRI Radiomics for Prediction of Tumor Response and Downstaging in Rectal Cancer Patients after Preoperative Chemoradiation. Adv Radiat Oncol. 2020;5(6):1286–95. (PMID: 33305090771856010.1016/j.adro.2020.04.016)
Shaish H, Aukerman A, Vanguri R, Spinelli A, Armenta P, Jambawalikar S, et al. Radiomics of MRI for pretreatment prediction of pathologic complete response, tumor regression grade, and neoadjuvant rectal score in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation: an international multicenter study. Eur Radiol. 2020;30(11):6263–73. (PMID: 3250019210.1007/s00330-020-06968-6)
Nougaret S, Vargas HA, Lakhman Y, Sudre R, Do RK, Bibeau F, et al. Intravoxel Incoherent Motion-derived Histogram Metrics for Assessment of Response after Combined Chemotherapy and Radiation Therapy in Rectal Cancer: Initial Experience and Comparison between Single-Section and Volumetric Analyses. Radiology. 2016;280(2):446–54. (PMID: 2691956210.1148/radiol.2016150702)
Wang J, Liu X, Hu B, Gao Y, Chen J, Li J. Development and validation of an MRI-based radiomic nomogram to distinguish between good and poor responders in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy. Abdom Radiol (NY). 2021;46(5):1805–15. (PMID: 3315135910.1007/s00261-020-02846-3)
Zhou X, Yi Y, Liu Z, Cao W, Lai B, Sun K, et al. Radiomics-Based Pretherapeutic Prediction of Non-response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer. Ann Surg Oncol. 2019;26(6):1676–84. (PMID: 30887373651088210.1245/s10434-019-07300-3)
Petresc B, Lebovici A, Caraiani C, Feier DS, Graur F, Buruian MM. Pre-Treatment T2-WI Based Radiomics Features for Prediction of Locally Advanced Rectal Cancer Non-Response to Neoadjuvant Chemoradiotherapy: A Preliminary Study. Cancers (Basel). 2020;12(7).
Ejaz A, Casadaban L, Maker AV. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis. J Surg Res. 2017;215:12–20. (PMID: 28688636560484610.1016/j.jss.2017.03.017)
Babcock BD, Aljehani MA, Jabo B, Choi AH, Morgan JW, Selleck MJ, et al. High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal. Ann Surg Oncol. 2018;25(7):1980–5. (PMID: 2967576210.1245/s10434-018-6484-8)
Nozawa H, Kawai K, Hata K, Tanaka T, Nishikawa T, Otani K, et al. High-risk Stage II Colorectal Cancers Carry an Equivalent Risk of Peritoneal Recurrence to Stage III. In Vivo. 2018;32(5):1235–40. (PMID: 30150450619961610.21873/invivo.11370)
Sun Y, Hu P, Wang J, Shen L, Xia F, Qing G, et al. Radiomic features of pretreatment MRI could identify T stage in patients with rectal cancer: Preliminary findings. J Magn Reson Imaging. 2018.
Yuan Y, Lu H, Ma X, Chen F, Zhang S, Xia Y, et al. Is rectal filling optimal for MRI-based radiomics in preoperative T staging of rectal cancer? Abdom Radiol (NY). 2022;47(5):1741–9. (PMID: 3526707010.1007/s00261-022-03477-6)
Chen J, Chen Y, Zheng D, Pang P, Zhang H, Zheng X, et al. Pretreatment MR-based radiomics nomogram as potential imaging biomarker for individualized assessment of perineural invasion status in rectal cancer. Abdom Radiol (NY). 2021;46(3):847–57. (PMID: 3287034910.1007/s00261-020-02710-4)
Guo Y, Wang Q, Zhang Y, Fu Y, Zhang H. Preoperative prediction of perineural invasion with multi-modality radiomics in rectal cancer. Sci Rep. 2021;11(1):9429. (PMID: 33941817809321310.1038/s41598-021-88831-2)
Yang YS, Qiu YJ, Zheng GH, Gong HP, Ge YQ, Zhang YF, et al. High resolution MRI-based radiomic nomogram in predicting perineural invasion in rectal cancer. Cancer Imaging. 2021;21(1):40. (PMID: 34039436815766410.1186/s40644-021-00408-4)
Li M, Jin YM, Zhang YC, Zhao YL, Huang CC, Liu SM, et al. Radiomics for predicting perineural invasion status in rectal cancer. World J Gastroenterol. 2021;27(33):5610–21. (PMID: 34588755843361810.3748/wjg.v27.i33.5610)
Zhang Y, Peng J, Liu J, Ma Y, Shu Z. Preoperative Prediction of Perineural Invasion Status of Rectal Cancer Based on Radiomics Nomogram of Multiparametric Magnetic Resonance Imaging. Front Oncol. 2022;12:828904. (PMID: 35480114903637210.3389/fonc.2022.828904)
Yu X, Song W, Guo D, Liu H, Zhang H, He X, et al. Preoperative Prediction of Extramural Venous Invasion in Rectal Cancer: Comparison of the Diagnostic Efficacy of Radiomics Models and Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging. Front Oncol. 2020;10:459. (PMID: 32328461716069410.3389/fonc.2020.00459)
Liu S, Yu X, Yang S, Hu P, Hu Y, Chen X, et al. Machine Learning-Based Radiomics Nomogram for Detecting Extramural Venous Invasion in Rectal Cancer. Front Oncol. 2021;11:610338. (PMID: 33842316803303210.3389/fonc.2021.610338)
Zhao L, Liang M, Wang S, Yang Y, Zhang H, Zhao X. Preoperative evaluation of extramural venous invasion in rectal cancer using radiomics analysis of relaxation maps from synthetic MRI. Abdom Radiol (NY). 2021;46(8):3815–25. (PMID: 3374301710.1007/s00261-021-03021-y)
Shu Z, Mao D, Song Q, Xu Y, Pang P, Zhang Y. Multiparameter MRI-based radiomics for preoperative prediction of extramural venous invasion in rectal cancer. Eur Radiol. 2022;32(2):1002–13. (PMID: 3448242910.1007/s00330-021-08242-9)
Zhu H, Zhang X, Li X, Shi Y, Sun Y. Prediction of pathological nodal stage of locally advanced rectal cancer by collective features of multiple lymph nodes in magnetic resonance images before and after neoadjuvant chemoradiotherapy. Chin J Cancer Res. 2019;31(6):984–92. (PMID: 31949400695515910.21147/j.issn.1000-9604.2019.06.14)
Bodalal Z, Trebeschi S, Nguyen-Kim TDL, Schats W, Beets-Tan R. Radiogenomics: bridging imaging and genomics. Abdom Radiol (NY). 2019;44(6):1960–84. (PMID: 3104961410.1007/s00261-019-02028-w)
Rutman AM, Kuo MD. Radiogenomics: creating a link between molecular diagnostics and diagnostic imaging. Eur J Radiol. 2009;70(2):232–41. (PMID: 1930323310.1016/j.ejrad.2009.01.050)
Van Cutsem E, Lenz HJ, Köhne CH, Heinemann V, Tejpar S, Melezínek I, et al. Fluorouracil, leucovorin, and irinotecan plus cetuximab treatment and RAS mutations in colorectal cancer. J Clin Oncol. 2015;33(7):692–700. (PMID: 2560584310.1200/JCO.2014.59.4812)
Cui Y, Cui X, Yang X, Zhuo Z, Du X, Xin L, et al. Diffusion kurtosis imaging-derived histogram metrics for prediction of KRAS mutation in rectal adenocarcinoma: Preliminary findings. J Magn Reson Imaging. 2019;50(3):930–9. (PMID: 3063786110.1002/jmri.26653)
Oh JE, Kim MJ, Lee J, Hur BY, Kim B, Kim DY, et al. Magnetic Resonance-Based Texture Analysis Differentiating KRAS Mutation Status in Rectal Cancer. Cancer Res Treat. 2020;52(1):51–9. (PMID: 3109673610.4143/crt.2019.050)
Horvat N, Veeraraghavan H, Pelossof RA, Fernandes MC, Arora A, Khan M, et al. Radiogenomics of rectal adenocarcinoma in the era of precision medicine: A pilot study of associations between qualitative and quantitative MRI imaging features and genetic mutations. Eur J Radiol. 2019;113:174–81. (PMID: 30927944644310010.1016/j.ejrad.2019.02.022)
Xu Y, Xu Q, Ma Y, Duan J, Zhang H, Liu T, et al. Characterizing MRI features of rectal cancers with different KRAS status. BMC Cancer. 2019;19(1):1111. (PMID: 31727020685723310.1186/s12885-019-6341-6)
Xu Y, Xu Q, Sun H, Liu T, Shi K, Wang W. Could IVIM and ADC help in predicting the KRAS status in patients with rectal cancer? Eur Radiol. 2018;28(7):3059–65. (PMID: 2945071610.1007/s00330-018-5329-y)
Cui Y, Liu H, Ren J, Du X, Xin L, Li D, et al. Development and validation of a MRI-based radiomics signature for prediction of KRAS mutation in rectal cancer. Eur Radiol. 2020;30(4):1948–58. (PMID: 3194267210.1007/s00330-019-06572-3)
Yeo DM, Oh SN, Choi MH, Lee SH, Lee MA, Jung SE. Histogram Analysis of Perfusion Parameters from Dynamic Contrast-Enhanced MR Imaging with Tumor Characteristics and Therapeutic Response in Locally Advanced Rectal Cancer. Biomed Res Int. 2018;2018:3724393. (PMID: 30186857611001310.1155/2018/3724393)
Guo XF, Yang WQ, Yang Q, Yuan ZL, Liu YL, Niu XH, et al. Feasibility of MRI Radiomics for Predicting KRAS Mutation in Rectal Cancer. Curr Med Sci. 2020;40(6):1156–60. (PMID: 3342814410.1007/s11596-020-2298-6)
Meng X, Xia W, Xie P, Zhang R, Li W, Wang M, et al. Preoperative radiomic signature based on multiparametric magnetic resonance imaging for noninvasive evaluation of biological characteristics in rectal cancer. Eur Radiol. 2018.
Lovinfosse P, Koopmansch B, Lambert F, Jodogne S, Kustermans G, Hatt M, et al. (18)F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status. Br J Radiol. 2016;89(1063):20160212. (PMID: 27146067525733210.1259/bjr.20160212)
Jang BS, Song C, Kang SB, Kim JS. Radiogenomic and Deep Learning Network Approaches to Predict. Anticancer Res. 2021;41(8):3969–76. (PMID: 3428186010.21873/anticanres.15193)
Yuan H, Peng Y, Xu X, Tu S, Wei Y, Ma Y. A Tumoral and Peritumoral CT-Based Radiomics and Machine Learning Approach to Predict the Microsatellite Instability of Rectal Carcinoma. Cancer Manag Res. 2022;14:2409–18. (PMID: 35971393937556410.2147/CMAR.S377138)
Zhang W, Huang Z, Zhao J, He D, Li M, Yin H, et al. Development and validation of magnetic resonance imaging-based radiomics models for preoperative prediction of microsatellite instability in rectal cancer. Ann Transl Med. 2021;9(2):134. (PMID: 33569436786794410.21037/atm-20-7673)
Li Z, Dai H, Liu Y, Pan F, Yang Y, Zhang M. Radiomics Analysis of Multi-Sequence MR Images For Predicting Microsatellite Instability Status Preoperatively in Rectal Cancer. Front Oncol. 2021;11:697497. (PMID: 34307164829390010.3389/fonc.2021.697497)
Li M, Zhu YZ, Zhang YC, Yue YF, Yu HP, Song B. Radiomics of rectal cancer for predicting distant metastasis and overall survival. World J Gastroenterol. 2020;26(33):5008–21. (PMID: 32952346747617010.3748/wjg.v26.i33.5008)
Chen F, Ma X, Li S, Li Z, Jia Y, Xia Y, et al. MRI-Based Radiomics of Rectal Cancer: Assessment of the Local Recurrence at the Site of Anastomosis. Acad Radiol. 2021;28(Suppl 1):S87–94. (PMID: 3316231810.1016/j.acra.2020.09.024)
Jeon SH, Song C, Chie EK, Kim B, Kim YH, Chang W, et al. Delta-radiomics signature predicts treatment outcomes after preoperative chemoradiotherapy and surgery in rectal cancer. Radiat Oncol. 2019;14(1).
Meng Y, Zhang Y, Dong D, Li C, Liang X, Zhang C, et al. Novel radiomic signature as a prognostic biomarker for locally advanced rectal cancer. J Magn Reson Imaging. 2018.
Chuanji Z, Zheng W, Shaolv L, Linghou M, Yixin L, Xinhui L, et al. Comparative study of radiomics, tumor morphology, and clinicopathological factors in predicting overall survival of patients with rectal cancer before surgery. Transl Oncol. 2022;18:101352. (PMID: 35144092884480110.1016/j.tranon.2022.101352)
Fan S, Cui X, Liu C, Li X, Zheng L, Song Q, et al. CT-Based Radiomics Signature: A Potential Biomarker for Predicting Postoperative Recurrence Risk in Stage II Colorectal Cancer. Front Oncol. 2021;11:644933. (PMID: 33816297801733710.3389/fonc.2021.644933)
Nie K, Hu P, Zheng J, Zhang Y, Yang P, Jabbour SK, et al. Incremental Value of Radiomics in 5-Year Overall Survival Prediction for Stage II-III Rectal Cancer. Front Oncol. 2022;12:779030. (PMID: 35847948927966210.3389/fonc.2022.779030)
Wang F, Tan BF, Poh SS, Siow TR, Lim FLWT, Yip CSP, et al. Predicting outcomes for locally advanced rectal cancer treated with neoadjuvant chemoradiation with CT-based radiomics. Sci Rep. 2022;12(1):6167. (PMID: 35418656900812210.1038/s41598-022-10175-2)
Tibermacine H, Rouanet P, Sbarra M, Forghani R, Reinhold C, Nougaret S, et al. Radiomics modelling in rectal cancer to predict disease-free survival: evaluation of different approaches. Br J Surg. 2021;108(10):1243–50. (PMID: 3442334710.1093/bjs/znab191)
Morin O, Vallières M, Jochems A, Woodruff HC, Valdes G, Braunstein SE, et al. A Deep Look Into the Future of Quantitative Imaging in Oncology: A Statement of Working Principles and Proposal for Change. Int J Radiat Oncol Biol Phys. 2018;102(4):1074–82. (PMID: 3017010110.1016/j.ijrobp.2018.08.032)
Horvat N, Miranda J, El Homsi M, Peoples JJ, Long NM, Simpson AL, Do RKG. A primer on texture analysis in abdominal radiology. Abdom Radiol (NY). 2022 Sep;47(9):2972–85. https://doi.org/10.1007/s00261-021-03359-3 . Epub 2021 Nov 26. PMID: 34825946.
Song L, Yin J. Application of texture analysis based on sagittal fat-suppression and oblique axial T2-weighted magnetic resonance imaging to identify lymph node invasion status of rectal cancer. Front Oncol. 2020;10:1364. (PMID: 32850437742651810.3389/fonc.2020.01364)
Zhou X, Yi Y, Liu Z, Zhou Z, Lai B, Sun K, et al. Radiomics-based preoperative prediction of lymph node status following neoadjuvant therapy in locally advanced rectal cancer. Front Oncol. 2020;10:604. (PMID: 32477930723311810.3389/fonc.2020.00604)
Liu X, Yang Q, Zhang C, Sun J, He K, Xie Y, et al. Multiregional-based magnetic resonance imaging radiomics combined with clinical data improves efficacy in predicting lymph node metastasis of rectal cancer. Front Oncol. 2020;10:585767.
Su Y, Zhao H, Liu P, Zhang L, Jiao Y, Xu P, et al. A nomogram model based on MRI and radiomic features developed and validated for the evaluation of lymph node metastasis in patients with rectal cancer. Abdom Radiol (NY). 2022.
Song G, Li P, Wu R, Jia Y, Hong Y, He R, et al. Development and validation of a high-resolution T2WI-based radiomic signature for the diagnosis of lymph node status within the mesorectum in rectal cancer. Front Oncol. 2022;12:945559.
Wang D, Zhuang Z, Wu S, Chen J, Fan X, Liu M, et al. A dual-energy CT radiomics of the regional largest short-axis lymph node can improve the prediction of lymph node metastasis in patients with rectal cancer. Front Oncol. 2022;12:846840.
Zhang YC, Li M, Jin YM, Xu JX, Huang CC, Song B. Radiomics for differentiating tumor deposits from lymph node metastasis in rectal cancer. World J Gastroenterol. 2022;28(29):3960–70. (PMID: 36157536936722210.3748/wjg.v28.i29.3960)
Yang YS, Feng F, Qiu YJ, Zheng GH, Ge YQ, Wang YT. High-resolution MRI-based radiomics analysis to predict lymph node metastasis and tumor deposits respectively in rectal cancer. Abdom Radiol (NY). 2021;46(3):873–84. (PMID: 3294075510.1007/s00261-020-02733-x)
Hu P, Wang J, Zhong H, Zhou Z, Shen L, Hu W, et al. Reproducibility with repeat CT in radiomics study for rectal cancer. Oncotarget. 2016;7(44):71440–6. (PMID: 27669756534209010.18632/oncotarget.12199)
Meng Y, Zhang C, Zou S, Zhao X, Xu K, Zhang H, et al. MRI texture analysis in predicting treatment response to neoadjuvant chemoradiotherapy in rectal cancer. Oncotarget. 2018;9(15):11999–2008. (PMID: 2955228810.18632/oncotarget.23813)
Aker M, Ganeshan B, Afaq A, Wan S, Groves AM, Arulampalam T. Magnetic resonance texture analysis in identifying complete pathological response to neoadjuvant treatment in locally advanced rectal cancer. Dis Colon Rectum. 2019;62(2):163–70. (PMID: 3045176410.1097/DCR.0000000000001224)
Traverso A, Kazmierski M, Shi Z, Kalendralis P, Welch M, Nissen HD, et al. Stability of radiomic features of apparent diffusion coefficient (ADC) maps for locally advanced rectal cancer in response to image pre-processing. Phys Med. 2019;61:44–51. (PMID: 3115157810.1016/j.ejmp.2019.04.009)
Huang Z, Zhang W, He D, Cui X, Tian S, Yin H, et al. Development and validation of a radiomics model based on T2WI images for preoperative prediction of microsatellite instability status in rectal cancer: Study Protocol Clinical Trial (SPIRIT Compliant). Medicine (Baltimore). 2020;99(10):e19428.
Palmisano A, Di Chiara A, Esposito A, Rancoita PMV, Fiorino C, Passoni P, et al. MRI prediction of pathological response in locally advanced rectal cancer: when apparent diffusion coefficient radiomics meets conventional volumetry. Clin Radiol. 2020;75(10):798.e1–798.e11. (PMID: 3271200710.1016/j.crad.2020.06.023)
Yang C, Jiang ZK, Liu LH, Zeng MS. Pre-treatment ADC image-based random forest classifier for identifying resistant rectal adenocarcinoma to neoadjuvant chemoradiotherapy. Int J Colorectal Dis. 2020;35(1):101–7. (PMID: 3178665210.1007/s00384-019-03455-3)
Lu H, Yuan Y, Zhou Z, Ma X, Shen F, Xia Y, et al. Assessment of MRI-based radiomics in preoperative T staging of rectal cancer: Comparison between minimum and maximum delineation methods. Biomed Res Int. 2021;2021:5566885.
Chen Y, Li B, Jiang Z, Li H, Dang Y, Tang C, et al. Multi-parameter diffusion and perfusion magnetic resonance imaging and radiomics nomogram for preoperative evaluation of aquaporin-1 expression in rectal cancer. Abdom Radiol (NY). 2022;47(4):1276–90. (PMID: 3516693810.1007/s00261-021-03397-x)
Linsalata S, Borgheresi R, Marfisi D, Barca P, Sainato A, Paiar F, et al. Radiomics of patients with locally advanced rectal cancer: Effect of preprocessing on features estimation from computed tomography imaging. Biomed Res Int. 2022;2022:2003286.
Rai R, Barton MB, Chlap P, Liney G, Brink C, Vinod S, et al. Repeatability and reproducibility of magnetic resonance imaging-based radiomic features in rectal cancer. J Med Imaging (Bellingham). 2022;9(4):044005.
Schurink NW, van Kranen SR, Roberti S, van Griethuysen JJM, Bogveradze N, Castagnoli F, et al. Sources of variation in multicenter rectal MRI data and their effect on radiomics feature reproducibility. Eur Radiol. 2021.
Wu YQ, Gao RZ, Lin P, Wen R, Li HY, Mou MY, et al. An endorectal ultrasound-based radiomics signature for preoperative prediction of lymphovascular invasion of rectal cancer. BMC Med Imaging. 2022;22(1):84. (PMID: 35538520908795810.1186/s12880-022-00813-6)
معلومات مُعتمدة: P30 CA008748 United States CA NCI NIH HHS; P30 CA008748 United States CA NCI NIH HHS
فهرسة مساهمة: Keywords: Computed tomography; Magnetic resonance imaging; Positron emission tomography; Radiomics; Rectal cancer; Texture analysis
تواريخ الأحداث: Date Created: 20230508 Date Completed: 20231229 Latest Revision: 20231229
رمز التحديث: 20231229
DOI: 10.1007/s12029-022-00909-w
PMID: 37155130
قاعدة البيانات: MEDLINE
الوصف
تدمد:1941-6636
DOI:10.1007/s12029-022-00909-w